Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PACTR202204798992849Phase 4Not yet recruiting
Phase 4, open-label trial of bupivacaine in postoperative pain (2 arms). Primary endpoint: Time to first rescue analgesic requirement postoperatively. Planned start Apr 2022; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on PACTR202204798992849.